scanX
Home
Marksans Pharma

Marksans Pharma

281.22
-15.17
(-5.12%)
Market Cap (₹ Cr.)
₹13,425
52 Week High
298.00
Book Value
₹46
52 Week Low
97.45
PE Ratio
40.20
PB Ratio
6.50
PE for Sector
57.62
PB for Sector
19.92
ROE
15.03 %
ROCE
53.12 %
Dividend Yield
0.20 %
EPS
₹7.37
Industry
Pharmaceuticals
Sector
Pharmaceuticals - Indian - Formulations
Live Chart
comparison:

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Growth Rate
Revenue Growth
16.55 %
Net Income Growth
18.68 %
Cash Flow Change
-2.95 %
ROE
0.43 %
ROCE
-21.11 %
EBITDA Margin (Avg.)
9.55 %

Financial Results

Quarterly Financials
Mar 2015
Jun 2015
Sept 2015
Dec 2015
Mar 2016
Jun 2016
Sept 2016
Dec 2016
Mar 2017
Jun 2017
Sept 2017
Dec 2017
Mar 2018
Jun 2018
Sept 2018
Dec 2018
Mar 2019
Jun 2019
Sept 2019
Dec 2019
Mar 2020
Jun 2020
Sept 2020
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Revenue
95
105
117
69
76
42
62
65
54
52
75
80
87
96
117
125
101
95
109
117
114
156
151
175
149
161
177
178
184
179
191
188
157
215
221
243
237
263
Expenses
74
65
76
51
62
31
56
51
53
45
69
69
76
76
97
108
88
82
88
97
95
127
115
134
111
122
135
138
149
148
136
149
130
155
167
199
191
213
EBITDA
21
39
41
19
14
11
6
14
1
8
6
12
11
20
21
17
13
12
21
20
18
29
36
41
39
39
43
40
35
31
55
40
27
59
53
43
46
49
Operating Profit %
19 %
36 %
35 %
27 %
10 %
25 %
-1 %
21 %
1 %
15 %
8 %
14 %
12 %
18 %
16 %
14 %
4 %
11 %
13 %
17 %
16 %
19 %
17 %
21 %
19 %
17 %
20 %
17 %
15 %
7 %
20 %
14 %
15 %
15 %
18 %
17 %
15 %
16 %
Depreciation
2
3
4
4
4
4
4
4
4
4
3
3
3
2
2
2
2
3
3
3
3
3
4
4
4
4
4
5
5
5
5
4
4
5
9
8
7
7
Interest
2
2
2
1
1
1
1
1
2
1
3
1
3
2
2
1
2
2
2
1
2
1
1
1
2
1
1
1
1
1
1
1
1
0
0
0
0
0
Profit Before Tax
17
34
36
13
8
6
2
9
-5
3
1
8
6
17
17
14
9
8
16
16
13
25
31
36
32
34
37
35
29
26
49
35
23
54
45
35
38
42
Tax
5
10
7
-1
4
0
-1
2
-2
0
1
1
1
2
4
3
2
2
3
3
3
6
6
8
8
6
8
9
8
7
9
9
5
8
12
10
9
10
Net Profit
12
24
29
14
5
4
3
7
-2
1
1
6
4
14
12
12
6
6
12
13
7
22
24
29
24
29
28
26
21
19
40
26
18
44
31
25
33
32
EPS in ₹
0.30
0.58
0.70
0.34
0.12
0.10
0.07
0.17
-0.06
0.03
0.03
0.14
0.11
0.34
0.30
0.29
0.14
0.14
0.29
0.32
0.18
0.54
0.57
0.71
0.58
0.71
0.67
0.64
0.52
0.47
1.00
0.63
0.43
0.98
0.69
0.56
0.73
0.71
Above figures are in Rs. Crores

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Total Assets
527
534
546
557
612
600
741
966
1,345
1,516
Fixed Assets
90
97
94
88
103
115
129
136
144
272
Current Assets
369
204
217
233
272
244
371
590
914
948
Capital Work in Progress
0
0
0
0
0
0
0
0
4
0
Investments
0
0
234
236
236
236
236
237
266
293
Other Assets
437
437
217
233
273
249
375
594
931
952
Total Liabilities
169
112
127
128
141
94
141
181
234
293
Current Liabilities
168
111
110
111
123
69
117
167
217
272
Non Current Liabilities
1
0
17
17
18
25
24
14
17
21
Total Equity
358
423
419
429
471
506
600
785
1,111
1,223
Reserve & Surplus
305
369
378
388
430
465
559
744
1,066
1,177
Share Capital
53
53
41
41
41
41
41
41
45
45
Above figures are in Rs. Crores

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Net Cash Flow
134
-164
-1
-2
1
2
102
-1
67
-106
Investing Activities
-29
-177
-8
-8
-20
-24
9
-128
-195
-114
Operating Activities
112
65
-14
16
20
108
107
56
52
34
Financing Activities
51
-52
21
-10
1
-82
-14
71
210
-26
Above figures are in Rs. Crores

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Jan 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Promoter
48.25 %
48.25 %
48.25 %
48.25 %
48.25 %
48.25 %
48.60 %
49.00 %
43.80 %
43.85 %
43.85 %
43.85 %
43.85 %
43.85 %
43.87 %
FIIs
3.34 %
2.55 %
2.64 %
2.59 %
3.46 %
4.04 %
4.06 %
4.24 %
3.94 %
4.23 %
4.02 %
4.19 %
4.68 %
4.69 %
7.71 %
DIIs
1.34 %
1.15 %
0.53 %
0.41 %
0.46 %
0.95 %
0.95 %
0.96 %
11.76 %
12.34 %
14.54 %
14.90 %
15.65 %
16.06 %
14.63 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.15 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
47.07 %
48.05 %
48.58 %
48.75 %
47.67 %
46.77 %
46.38 %
45.80 %
40.50 %
39.58 %
37.59 %
37.06 %
35.83 %
35.40 %
33.78 %

Peer Comparison Compare Peers on Screener

Competitors LTP Market Cap (₹ Cr.) P/E Ratio Revenue (₹ Cr.) YoY Revenue Growth % Net Profit (₹ Cr.) YoY Profit Growth % RSI
Torrent Pharmaceuticals
3,359.60 1,16,815.97 69.82 10,785.75 11.59 1,656 20.90 47.50
Ajanta Pharma
3,121.15 39,351.06 46.09 4,293.31 11.77 816 18.09 49.72
Gland Pharma
1,841.50 30,430.47 42.14 5,834.96 50.97 772 -25.94 37.24
Eris Lifesciences
1,397.05 18,928.93 49.77 2,032.96 19.85 397 -4.52 62.53
Caplin Point Laboratories
1,965.50 15,241.11 31.91 1,761.04 15.65 461 19.85 57.70
Marksans Pharma
281.22 13,424.98 40.20 2,227.83 16.55 315 26.45 67.40
Shilpa Medicare
901.90 8,720.99 212.33 1,159.77 8.64 32 1,091.53 73.96
Jeena Sikho Lifecare
1,406.80 3,353.63 100.45 207.35 40.06 34 - 55.67
Amrutanjan Health Care
804.90 2,253.29 52.91 192.42 12.50 21 -34.09 56.41
Syncom Formulations
23.18 2,241.90 79.50 238.85 3.11 20 73.41 56.92

Corporate Action

Technical Indicators

RSI(14)
Neutral
67.40
ATR(14)
Volatile
13.18
STOCH(9,6)
Overbought
83.00
STOCH RSI(14)
Neutral
66.67
MACD(12,26)
Bullish
2.13
ADX(14)
Very Strong Trend
53.58
UO(9)
Bearish
54.76
ROC(12)
Uptrend But Slowing Down
17.17
WillR(14)
Neutral
-26.49
Bearish
5
Neutral
3
Bullish
1
raisewe are part of Raise Financial Services
Heart
built with love

for indians who love to invest & trade

Explore
Technical Screeners
Price & Volume Screeners
Candlestick Screeners
Intraday Screeners
Fundamental Screeners
Bullish Stocks Today
Bearish Stocks Today
Stocks Nearing 52W High & Low
Rise & Fall Stocks
Index
Sector
Stock Heatmap
Companies
About Scanx

We’re building Scanx - to help you express your trading & investing idea, to help you analyse the markets better.

Stock Markets are the true indicator of the growth of any country's economy. We are bullish on India, we are bullish on India's prospects to be one of largest economies of the world. We believe that Stock Markets provide an unique opportunity for all Indians to participate in the growth story of India. We are enabling the same for Indians.
As financial services are becoming more accessible, there is now a large set of Indians today who are financially aware and literate. They value time and seek high quality products & services. Most screening, trading, investing platforms available today are more or less similar to each other, and they have not evolved with time. While both traders & investors have gotten smart about how they make money and build wealth, as users they have continued to use the same products, features, and platforms that were available for years with little or no innovation. We plan to change that - a technology-led platform built for super traders and long term investors.

© 2024 Moneylicious Securities Pvt. Ltd. All rights reserved.

Part of Raise Financial Services

Corporate Office: A-302, The Western Edge I, Off Western Express Highway, Borivali East, Mumbai – 400066, Maharashtra, India. Land Line: 022-43116666.